Vėžio diagnostikos rinkiniai

Vėžio diagnostikos rinkiniai

Transform your cancer diagnostics and clinical research with specialized kits from leading manufacturers Entrogen and Angle. Detect critical cancer biomarkers swiftly and accurately with Entrogen’s PCR-based detection kits, and utilize Angle’s FDA-approved Parsortix® system to isolate rare circulating tumor cells efficiently for liquid biopsy analyses. These state-of-the-art diagnostic tools facilitate early cancer detection, personalised treatment planning, and non-invasive disease monitoring, significantly improving patient outcomes.

Key benefits of our Cancer Diagnostic Kits include:

• Highly sensitive PCR assays for precise biomarker detection.
• Non-invasive liquid biopsy for circulating tumor cells (CTCs).
• Rapid, accurate results aiding personalised medicine.

Advance your cancer diagnostic capabilities today, delivering precision, early detection, and effective patient care.